{
    "2020-08-21": [
        [
            {
                "time": "2020-08-21",
                "original_text": "暴漲161.47%！疫情或催生疫苗板块成最大赢家",
                "features": {
                    "keywords": [
                        "暴涨",
                        "疫情",
                        "疫苗板块"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-21",
                "original_text": "智飞生物现1笔大宗交易 共成交229.27万元",
                "features": {
                    "keywords": [
                        "智飞生物",
                        "大宗交易"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-08-21",
                "original_text": "43家业绩超预期公司股价翻倍，智飞生物、歌尔股份等在此列",
                "features": {
                    "keywords": [
                        "业绩超预期",
                        "股价翻倍",
                        "智飞生物",
                        "歌尔股份"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "电子"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-08-21",
                "original_text": "A股早报2020年8月21日星期五",
                "features": {
                    "keywords": [],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-08-21",
                "original_text": "机构再接大宗能否带来智飞生物第四次起跳？",
                "features": {
                    "keywords": [
                        "机构",
                        "大宗",
                        "智飞生物"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}